熟练护理机构急性后期护理中谵妄的持续存在
该横断面研究基于5%医疗保险随机样本,比较2014年与2019年熟练护理机构入院时谵妄患者后续评估中谵妄缓解、持续和死亡的比例变化。结果显示入院谵妄患病率从4.3%(6933/162161)降至2.5%(3595/144837);调整后持续性谵妄从62.3%(95%CI 60.2%-64.4%)降至54.7%(95%CI 52.0%-57.4%),谵妄缓解从29.1%(95%CI 27.1%-31.1%)升至37.4%(95%CI 34.7%-40.0%)。作者认为持续谵妄高 prevalence 仍需进一步努力改善管理。
要点
- 2014年熟练护理机构入院谵妄患病率为4.3%(6933/162161),2019年降至2.5%(3595/144837)。
- 调整后持续性谵妄从2014年62.3%(95%CI 60.2%-64.4%)降至2019年54.7%(95%CI 52.0%-57.4%)。
- 调整后谵妄缓解从2014年29.1%(95%CI 27.1%-31.1%)升至2019年37.4%(95%CI 34.7%-40.0%)。
- 作者认为持续性谵妄的高患病率需要进一步努力改善熟练护理机构的谵妄管理。
- 谵妄采用最小数据集(MDS)谵妄评估法在入院时及入院30天内后续评估中测量。
适用人群与场景
- 纳入5%医疗保险随机样本中2014年1月1日至12月31日及2019年1月1日至12月31日期间入熟练护理机构的患者。
- 持续性谵妄分析纳入熟练护理机构入院时有谵妄且住院期间有后续谵妄评估的患者。
- 排除后样本共306998例入院;2014年有随访评估的谵妄患者6096例(平均[SD]年龄80.6[11.0]岁,女性3565例[58.5%]),2019年2778例(平均[SD]年龄80.2[10.7]岁,女性1546例[55.7%])。
诊断标准与关键阈值
- 谵妄采用最小数据集(MDS)谵妄评估法在熟练护理机构入院时及入院30天内后续评估中测量。
研究设计与关键结果
- 研究设计为横断面研究,样本来自5%医疗保险随机样本,比较2019年与2014年熟练护理机构入院谵妄的持续与缓解情况。
- 排除前熟练护理机构入院共432037例,排除后306998例。
- 2014年入院谵妄患病率为4.3%(6933/162161),2019年为2.5%(3595/144837)。
- 调整后持续性谵妄从2014年62.3%(3347/6096;95%CI 60.2%-64.4%)降至2019年54.7%(1316/2778;95%CI 52.0%-57.4%)。
- 调整后谵妄缓解从2014年29.1%(1734/6096;95%CI 27.1%-31.1%)升至2019年37.4%(1010/2778;95%CI 34.7%-40.0%)。
- 采用多项逻辑回归比较2014年与2019年谵妄缓解、持续和死亡的比例,调整患者特征和熟练护理机构护理因素。
证据类型、等级与局限
- 证据类型:横断面研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为持续性谵妄的高患病率需要进一步努力改善熟练护理机构的谵妄管理。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The 2014 Improving Medicare Post-Acute Care Transformation (IMPACT) Act aimed to improve postacute care quality and outcomes. This study examines changes in delirium, a key quality indicator, over 5 years following its implementation.
OBJECTIVE: To compare the persistence and resolution of delirium within skilled nursing facilities (SNFs) between 2014 and 2019.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study included SNF admissions from a 5% Medicare random sample, with delirium assessments conducted between January 1 and December 31 in 2014 and 2019. The analysis of persistent delirium consisted of patients with delirium at SNF admission and a subsequent delirium assessment during their SNF stay. Analyses were conducted from December 2023 to October 2024.
EXPOSURES: Year 2019 compared with year 2014.
MAIN OUTCOMES AND MEASURES: Delirium was measured using the Minimum Data Set (MDS) Confusion Assessment Method at SNF admission and at a subsequent assessment within 30 days of admission. Multinomial logistic regression was used to compare the rates of resolved delirium, persistent delirium, and death between 2014 and 2019 after adjusting for patient characteristics and SNF care factors.
RESULTS: The sample included a total of 432 037 SNF admissions before exclusions and 306 998 after exclusions. For SNF admissions in 2014, 6933 of 162 161 patients (4.3%) had delirium at admission, compared with 3595 of 144 837 patients (2.5%) in 2019. In 2014, there were 6096 patients (mean [SD] age, 80.6 [11.0] years; 3565 women [58.5%]), and in 2019, there were 2778 patients (mean [SD] age, 80.2 [10.7] years; 1546 women [55.7%]) with delirium and follow-up assessments. The adjusted prevalence of persistent delirium decreased from 3347 of 6096 patients (62.3%; 95% CI, 60.2%-64.4%) in 2014 to 1316 of 2778 patients (54.7%; 95% CI, 52.0%-57.4%) in 2019, whereas delirium resolution increased from 1734 of 6096 patients (29.1%; 95% CI, 27.1%-31.1%) in 2014 to 1010 of 2778 patients (37.4%; 95% CI, 34.7%-40.0%) in 2019.
CONCLUSIONS AND RELEVANCE: This cross-sectional study found a reduction in the prevalence of delirium at SNF admission and an improvement in delirium resolution during the stay in the 5 years following the IMPACT Act. However, the high prevalence of persistent delirium warrants further efforts to improve delirium management in SNF.
参考来源
- Park CM, Shi S, Jones RN, et al. Persistence of Delirium in Postacute Care at Skilled Nursing Facilities. JAMA Netw Open. 2025. PMID: 40094664. doi:10.1001/jamanetworkopen.2025.0860
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。